Mystic Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Sell
2,606
-4
-0.2% -$4.05K 0.56% 49
2025
Q4
$2.8M Sell
2,610
-25
-0.9% -$23.9K 0.63% 41
2025
Q3
$2.01M Buy
2,635
+37
+1% +$27.5K 0.45% 56
2025
Q2
$2.03M Sell
2,598
-70
-3% -$54.4K 0.49% 56
2025
Q1
$2.2M Buy
2,668
+50
+2% +$41.6K 0.58% 50
2024
Q4
$2.02M Buy
2,618
+51
+2% +$42.2K 0.54% 51
2024
Q3
$2.28M Buy
2,567
+63
+3% +$56.6K 0.86% 32
2024
Q2
$2.27M Sell
2,504
-182
-7% -$146K 0.92% 28
2024
Q1
$2.09M Buy
2,686
+48
+2% +$34.2K 0.86% 31
2023
Q4
$1.54M Sell
2,638
-80
-3% -$46.7K 0.74% 41
2023
Q3
$1.46M Sell
2,718
-125
-4% -$64.4K 0.82% 37
2023
Q2
$1.33M Sell
2,843
-168
-6% -$70.5K 0.71% 43
2023
Q1
$1.03M Sell
3,011
-125
-4% -$42.2K 0.57% 64
2022
Q4
$1.15M Sell
3,136
-107
-3% -$37.9K 0.65% 54
2022
Q3
$1.05M Sell
3,243
-20
-0.6% -$6.34K 0.67% 52
2022
Q2
$1.06M Sell
3,263
-360
-10% -$108K 0.64% 55
2022
Q1
$1.04M Hold
3,623
0.56% 64
2021
Q4
$1M Buy
+3,623
New +$918K 0.47% 67

Other funds holding LLY

Mystic Asset Management's LLY Position: Q1 2026 in Review

Mystic Asset Management reduced its Eli Lilly (LLY) stake by 0.15% in Q1 2026, selling an estimated $4.05K and leaving 2,606 shares worth $2.4M. The position accounts for 0.56% of the portfolio, ranked #49.

Mystic Asset Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mystic Asset Management held 2,606 shares of Eli Lilly worth $2.4M as of Q1 2026.
  • Mystic Asset Management sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.56% of Mystic Asset Management's portfolio in Q1 2026, its #49 holding.
  • Mystic Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Mystic Asset Management's Eli Lilly position peaked at $2.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.